IART INTEGRA LIFESCIENCES HOLDINGS CORP

8-K Current Report
Filed: February 26, 2026
Health Care
Surgical & Medical Instruments & Apparatus

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • Earnings release covers Q4 and full-year periods ended December 31, 2025; reconciliation tables included in press release exhibit
  • Goodwill impairment charges excluded from adjusted results — triggered by tariff uncertainty, quality/operational issues, and market cap decline, signaling material business stress
+3 more insights

Get deeper insights on INTEGRA LIFESCIENCES HOLDINGS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.